November 4, 2024
Implementing the Patient Health Questionnaire-2 (PHQ-2) in a hidradenitis suppurativa (HS) clinic improved the ability of dermatologists to detect patients at risk for depression, results from […]
November 4, 2024
TOPLINE: Weekend exercise, involving one or two sessions per week, is associated with a similar reduction in risk for mild dementia as that reported with more […]
November 4, 2024
SAVANNAH, Ga. — Should patients with myasthenia gravis (MG) continue to undergo the traditional therapy of immunosuppression with drugs like corticosteroids and nonsteroidal agents? Or is […]
November 4, 2024
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, […]
November 4, 2024
Many people with rheumatologic diseases try supplements for symptom relief. Here’s what you need to know about some common picks. Dietary supplements were a $159 billion […]
November 4, 2024
Individuals with hidradenitis suppurativa (HS) face a significantly increased risk for bulimia nervosa and binge eating disorder, an analysis of national data showed. Christopher Guirguis, DMD […]
November 1, 2024
For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
November 1, 2024
FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness
[11/1/2024] FDA is warning patients and health care professionals not to use drugs compounded and distributed by Fullerton Wellness LLC, Ontario, Calif., and distributed to patients […]
November 1, 2024
CHICAGO — Patients who are new users of glucagon-like peptide-1 (GLP-1) receptor agonists have a low absolute risk of thyroid cancer, according to a new study […]